Rare diseases
Investigational molecules
Locations
Back to Germany9 clinical trials in Geesthacht, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis
GermanyA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
GermanyStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
GermanyStudy on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy
GermanyStudy on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment
GermanyStudy on the Effectiveness and Safety of Taplucainium Inhalation Powder (NOC-110) for Adults with Refractory or Unexplained Chronic Cough
GermanyStudy on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough
GermanyStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma
GermanyStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on severe asthma treatments, including innovative therapies for patients with eosinophilic phenotype. Studies evaluate new combination inhalers and biological treatments to improve lung function and reduce exacerbations.
Multiple clinical trials are investigating both established and novel treatment approaches for better asthma control.
Innovative research targeting refractory and unexplained chronic cough, with trials examining new inhalation treatments and therapeutic compounds to reduce cough frequency in adult patients.
These studies aim to provide relief for patients with persistent cough conditions that don't respond to standard treatments.
Research examining immunotherapy treatments for moderate to severe allergic rhinitis and rhinoconjunctivitis, particularly focusing on house dust mite allergies and associated respiratory conditions.
Clinical trials evaluate the effectiveness of targeted immunotherapy in reducing allergy symptoms and improving quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
